The Use of Biologics in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Current Hepatology Reports
doi 10.1007/s11901-019-00456-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Primary Sclerosing Cholangitis With Inflammatory Bowel Disease in Korean Children

Pediatric Gastroenterology, Hepatology and Nutrition
Child HealthHepatologyPediatricsPerinatologyGastroenterology
2015English

Letter: Vedolizumab for the Management of Inflammatory Bowel Disease in Patients After Liver Transplantation for Primary Sclerosing Cholangitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease

Hepatology Communications
Hepatology
2018English

Primary Sclerosing Cholangitis

2017English

Primary Sclerosing Cholangitis

2012English

Primary Sclerosing Cholangitis

2020English

Primary Sclerosing Cholangitis

2013English

Impact of Age at Diagnosis on Disease Progression in Patients With Primary Sclerosing Cholangitis

United European Gastroenterology Journal
OncologyGastroenterology
2017English

Lack of Standardization in Exception Points for Patients With Primary Sclerosing Cholangitis and Bacterial Cholangitis

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy